PRE-EXPOSURE PROPHYLAXIS DRUG ASSISTANCE PROGRAM (PrEPDAP)

**PLEASE NOTE: For all COVID-19 updates regarding this program please visit COVID-19 and PrEPDAP**

The Massachusetts Pre-Exposure Prophylaxis Drug Assistance Program (PrEPDAP) helps Massachusetts residents pay for approved medications that can prevent the transmission of HIV. The program assists clients in need by covering out-of-pocket costs for HIV pre-exposure prophylaxis medications (including co-pays and payments towards a deductible). PrEPDAP can also cover the full cost of PrEP, for individuals who lack health insurance.  PrEPDAP clients seeking to enroll or change health insurance coverage are referred to our BRIDGE team. 

Two medications are currently approved by the FDA for use as pre-exposure prophylaxis:

  • emtricitabine/tenofovir disoproxil fumarate (Truvada and generic)
  • emtricitabine/tenofovir alafenamide fumarate (Descovy)

PrEPDAP is a program of the Office of HIV/AIDS in the Bureau of Infectious Diseases and Laboratory Sciences at the Massachusetts Department of Public Health and is administered by Community Research Initiative (CRI).

Kevin Herwig, Manager, HIV Biomedical Intervention Programs (617.502.1700 / kherwig@crine.org), recently discussed PrEPDAP on Farenheight TV - watch the episode to learn more about our program!

 

Communicating with PrEPDAP Staff

Please continue to contact PrEPDAP staff through our direct phone lines or by email:

Applications, documentation, and forms can continue to be faxed to PrEPDAP via our main fax line at 617-502-1701.

To submit client applications, forms or information via email, please use our secure email system by:

You may also reach us via email at prepdap@crine.org.